Skip to main content
| News

MyCamper is a European growth champion

12.03.2021

The Financial Times has included the Basel-based firm MyCamper in its list of the 1,000 fastest-growing start-ups in Europe. MyCamper acts as a broker for owners of motorhomes and campervans seeking to rent out their vehicles to tourists and vacationers. The company took 53rd place in the rankings.

The team of MyCamper is happy about the success (img: MyCamper)

In March, the Financial Times once again published its list of the 1,000 fastest-growing start-ups in Europe. MyCamper was the sole Swiss start-up to make the top 100, taking 53rd place in the process.

MyCamper brings together owners of motorhomes and campervans with vacationers. The start-up organizes vehicle rentals and takes care of insurance documentation and cleaning.

In order to be included in the Financial Times list, companies have to have recorded at least 35.5 percent growth in yearly sales between 2016 and 2019. For MyCamper, the annual growth rate was even as high as 171.5 percent, according to information from the newspaper. In 2019, the Basel-based company generated sales of approximately 3.06 million euros.

MyCamper was founded in 2015 and now employees a total of 17 full-time staff at its headquarters in Basel. In addition, there are two employees based in Stockholm, Sweden, and six who work out of Bosnia-Herzegovina.

For the company, the news that it had made the Financial Times rankings was “an emotional mega-booster, above all in terms of internal motivation”, explains MyCamper CEO Michele Matt in an interview with the newspaper “Handelszeitung”. He also commented that while his company experience a more restrained start to the new year, since February “the bookings have been coming in thick and fast!”. Camping has enjoyed a surge of popularity during the pandemic.

Alongside MyCamper, five other Swiss start-ups made the list of the best 1,000 firms. These are Frontify from St.Gallen (162nd place), eSMART Technologies based in Renens in the canton of Vaud (247th place), Catalyx (643rd place) and lemonads (989th place) – both from Geneva – in addition to the Aizo Group based in Schlieren in the canton of Zurich (991st place).

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Databaum establishes headquarters in Basel
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
New innovation campus opens in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
VectivBio raises 125 million US dollars in stock sale
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.